Patrick J Heron's Net Worth

$804 Million

Who is Patrick J Heron?

Patrick J Heron has an estimated net worth of $804 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Trubion Pharmaceuticals, Inc, Tarsus Pharmaceuticals, Inc., GLAUKOS Corp, ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., ANAPTYSBIO INC, Imago BioSciences, Inc., Sierra Oncology, Inc., Mirum Pharmaceuticals, Inc., Frazier Lifesciences Acquisition Corp, Cidara Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Passage BIO, Inc., Aptinyx Inc., HilleVax, Inc., and Regado Biosciences Inc.

SEC CIK

Patrick J Heron's CIK is 0001365617

Past Insider Trading and Trends

2020 was Patrick J Heron's most active year for acquiring shares with 26 total transactions. Patrick J Heron's most active month to acquire stocks was the month of April. 2018 was Patrick J Heron's most active year for disposing of shares, totalling 14 transactions. Patrick J Heron's most active month to dispose stocks was the month of September. 2022 saw Patrick J Heron paying a total of $73,012,773.50 for 4,921,713 shares, this is the most they've acquired in one year. In 2020 Patrick J Heron cashed out on 19,166,894 shares for a total of $250,010.00, their largest year based on trade value.